Exact Mass: 588.290748

Exact Mass Matches: 588.290748

Found 464 metabolites which its exact mass value is equals to given mass value 588.290748, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

D-Urobilin

DTXSID80331526

C33H40N4O6 (588.29477)

Avermectin B2b aglycone

C33H48O9 (588.3298158)

Dinoflagellate luciferin

C33H40N4O6 (588.29477)

A member of the class of bilenes that is 1,2,3,21-tetrahydro-5,7-ethanobilene-a-19(16H),5(2)-dione which is substituted at positions 2, 8, 13 and 18 by methyl groups and at positions 1, 3, 12 and 17 by carboxy, 2-carboxyethyl, ethyl and vinyl groups, respectively (the 1S,2S,3S diastereoisomer).

8,12-Diethylbacteriochlorophyllide d

magnesium;3-[(21S,22S)-11,26-diethyl-16-(1-hydroxyethyl)-12,17,21-trimethyl-4-oxo-23,25-diaza-7,24-diazanidahexacyclo[18.2.1.15,8.110,13.115,18.02,6]hexacosa-1,5,8(26),9,11,13(25),14,16,18,20(23)-decaen-22-yl]propanoic acid

C34H36MgN4O4 (588.2586916)

Sandoricin

Methyl 2-[5,11-bis(acetyloxy)-13-(furan-3-yl)-16-hydroxy-6,6,8,12-tetramethyl-17-methylidene-15-oxo-2,14-dioxatetracyclo[7.7.1.0¹,¹².0³,⁸]heptadecan-7-yl]acetic acid

C31H40O11 (588.257049)

Sandoricin is found in fruits. Sandoricin is a constituent of Sandoricum koetjape (santol). Constituent of Sandoricum koetjape (santol). Sandoricin is found in fruits.

Pentigetide

(2S)-2-[(Z)-{[(2S)-1-[(2S)-2-[(Z)-[(2S)-2-[(Z)-[(2S)-2-amino-3-carboxy-1-hydroxypropylidene]amino]-1,3-dihydroxypropylidene]amino]-3-carboxypropanoyl]pyrrolidin-2-yl](hydroxy)methylidene}amino]-5-carbamimidamidopentanoic acid

C22H36N8O11 (588.2503426)

D007155 - Immunologic Factors > D007132 - Immunoglobulin Isotypes C308 - Immunotherapeutic Agent > C574 - Immunosuppressant D007155 - Immunologic Factors > D007136 - Immunoglobulins D007155 - Immunologic Factors > D000906 - Antibodies Immunoglobulin E fragment. Immunoglobulin E fragment Pentigetide is a sythsis pepetide (Asp-Ser-Asp-Pro-Arg or D-S-D-P-R), also know as “HEPP” for “Human IgE Pentapeptide”. Pentigetide can not produce IgE inhibition in several different systems, due to the aspartic acids in HEPP changed into an asparagine[1].

(1RS,2RS)-2-(4-Hydroxyphenyl)-2-methyl-1-(9-(4,4,5,5,5-pentafluoropentyl)sulfinylnonyl)-1,2,3,4-tetrahydronaphth-6-ol

(1Rs,2Rs)-2-(4-Hydroxyphenyl)-2-methyl-1-(9-(4,4,5,5,5-pentafluoropentyl)sulphinylnonyl)-1,2,3,4-tetrahydronaphth-6-ol

C31H41F5O3S (588.2696416)

Cfp-aaf-pab

4-[(1-{[2-({2-[(1-carboxy-3-phenylpropyl)amino]-1-hydroxypropylidene}amino)-1-hydroxypropylidene]amino}-1-oxo-3-phenylpropan-2-yl)amino]benzoate

C32H36N4O7 (588.2583866)

Cilengitide

2-(5-benzyl-11-{3-[(diaminomethylidene)amino]propyl}-7-methyl-3,6,9,12,15-pentaoxo-8-(propan-2-yl)-1,4,7,10,13-pentaazacyclopentadecan-2-yl)acetic acid

C27H40N8O7 (588.3019810000001)

N(2)-(4-Hydroxy-1-(1-methyl-1H-indol-3-yl)carbonyl-L-prolyl)-N-methyl-N-phenylmethyl-3-(2-naphthyl)-L-alaninamide

N-[1-[benzyl(methyl)amino]-3-naphthalen-2-yl-1-oxopropan-2-yl]-4-hydroxy-1-(1-methylindole-3-carbonyl)pyrrolidine-2-carboxamide

C36H36N4O4 (588.2736416)

Flupentixol decanoate

2-(4-{3-[2-(trifluoromethyl)-9H-thioxanthen-9-ylidene]propyl}piperazin-1-yl)ethyl decanoic acid

C33H43F3N2O2S (588.2997174000001)

Ziritaxestat

2-[(2-ethyl-6-{4-[2-(3-hydroxyazetidin-1-yl)-2-oxoethyl]piperazin-1-yl}-8-methylimidazo[1,2-a]pyridin-3-yl)(methyl)amino]-4-(4-fluorophenyl)-1,3-thiazole-5-carbonitrile

C30H33FN8O2S (588.243109)

C78273 - Agent Affecting Respiratory System

Humilinolide A

C31H40O11 (588.257049)

Synechoxanthin

(all-trans)-chi,chi-Carotene-18,18-dioic acid

C40H44O4 (588.3239424)

D020011 - Protective Agents > D000975 - Antioxidants > D002338 - Carotenoids

Cimilactone B

piscidinol F

C33H48O9 (588.3298158)

elaeodendroside T

Tyr Asn His Arg

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(4-hydroxyphenyl)propanamido]-3-carbamoylpropanamido]-3-(1H-imidazol-4-yl)propanamido]-5-carbamimidamidopentanoic acid

NCGC00386085-01_C32H44O10_

C32H44O10 (588.2934324)

C31H40O11_7,11-Methano-2H,4H-oxireno[1,8]cycloocta[1,2-f][2]benzopyran-8-acetic acid, 4-(3-furanyl)dodecahydro-alpha,11-dihydroxy-4a,7,9,9-tetramethyl-10-(2-methyl-1-oxopropoxy)-2,13-dioxo-, methyl ester, (alphaR,4R,4aR,7S,8S,10S,11S,11aR,12aS)

NCGC00347533-02_C31H40O11_7,11-Methano-2H,4H-oxireno[1,8]cycloocta[1,2-f][2]benzopyran-8-acetic acid, 4-(3-furanyl)dodecahydro-alpha,11-dihydroxy-4a,7,9,9-tetramethyl-10-(2-methyl-1-oxopropoxy)-2,13-dioxo-, methyl ester, (alphaR,4R,4aR,7S,8S,10S,11S,11aR,12aS)-

C31H40O11 (588.257049)

(1S,2R,4S,9R,10R,14S,15S,17S)-9-(furan-3-yl)-1-hydroxy-15-[(1R)-1-hydroxy-2-methoxy-2-oxoethyl]-10,14,16,16-tetramethyl-7,18-dioxo-3,8-dioxapentacyclo[12.3.1.0²,⁴.0⁴,¹³.0⁵,¹⁰]octadecan-17-yl 2-methylpropanoate

(1S,2R,4S,9R,10R,14S,15S,17S)-9-(furan-3-yl)-1-hydroxy-15-[(1R)-1-hydroxy-2-methoxy-2-oxoethyl]-10,14,16,16-tetramethyl-7,18-dioxo-3,8-dioxapentacyclo[12.3.1.0²,⁴.0⁴,¹³.0⁵,¹⁰]octadecan-17-yl 2-methylpropanoate

C31H40O11 (588.257049)

methyl 2-[5,11-bis(acetyloxy)-13-(furan-3-yl)-16-hydroxy-6,6,8,12-tetramethyl-17-methylidene-15-oxo-2,14-dioxatetracyclo[7.7.1.0^{1,12}.0^{3,8}]heptadecan-7-yl]acetate

C31H40O11 (588.257049)

Pentyde

(2S)-2-{[(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carboxypropanamido]-3-hydroxypropanamido]-3-carboxypropanoyl]pyrrolidin-2-yl]formamido}-5-[(diaminomethylidene)amino]pentanoic acid

C22H36N8O11 (588.2503426)

D007155 - Immunologic Factors > D007132 - Immunoglobulin Isotypes C308 - Immunotherapeutic Agent > C574 - Immunosuppressant D007155 - Immunologic Factors > D007136 - Immunoglobulins D007155 - Immunologic Factors > D000906 - Antibodies Pentigetide is a sythsis pepetide (Asp-Ser-Asp-Pro-Arg or D-S-D-P-R), also know as “HEPP” for “Human IgE Pentapeptide”. Pentigetide can not produce IgE inhibition in several different systems, due to the aspartic acids in HEPP changed into an asparagine[1].

(2aR,3R,6bS,7aR,8S,9S,11S,12S)-3-(furan-3-yl)-8-hydroxy-11-((R)-1-hydroxy-2-methoxy-2-oxoethyl)-2a,10,10,12-tetramethyl-5,13-dioxododecahydro-2H,3H-8,12-methanooxireno[2,3:1,8]cycloocta[1,2-f]isochromen-9-yl isobutyrate

(2aR,3R,6bS,7aR,8S,9S,11S,12S)-3-(furan-3-yl)-8-hydroxy-11-((R)-1-hydroxy-2-methoxy-2-oxoethyl)-2a,10,10,12-tetramethyl-5,13-dioxododecahydro-2H,3H-8,12-methanooxireno[2,3:1,8]cycloocta[1,2-f]isochromen-9-yl isobutyrate

C31H40O11 (588.257049)

OKOOA-PA

1-(9Z-octadecenoyl)-2-(5,8-dioxo-6E-octenoyl)-sn-glycero-3-phosphate

C29H49O10P (588.3063184)

Flupentixol decanoate

C33H43F3N2O2S (588.2997174000001)

D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018492 - Dopamine Antagonists D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants C78272 - Agent Affecting Nervous System > C66883 - Dopamine Antagonist

Cyclo(-Arg-Ala-Asp-D-Phe-Val)

C27H40N8O7 (588.3019810000001)

5-[2,5-bis[2-(1,3,3-trimethylindol-2-ylidene)ethylidene]cyclopentylidene]-1,3-dimethyl-1,3-diazinane-2,4,6-trione

C37H40N4O3 (588.310025)

Z-Gly-Pro-Gly-Gly-Pro-Ala-OH

C27H36N6O9 (588.2543646)

Cilengitide

C27H40N8O7 (588.3019810000001)

C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor > C2144 - Endothelial-Specific Integrin/Survival Signaling Inhibitor D009676 - Noxae > D011042 - Poisons > D014688 - Venoms

(S)-2-[(S)-2-((S)-1-Ethoxycarbonyl-3-phenylpropylamino)propionyl]-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid benzyl ester

C34H40N2O7 (588.283537)

Procaine penicillin

Penicillin G Procaine

C29H40N4O7S (588.261757)

D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D010406 - Penicillins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic

BAPTA tetraethyl ester

C30H40N2O10 (588.268282)

mesobilirubin

C33H40N4O6 (588.29477)

N,N-Bis(naphthalene-2-yl)-N,N-bis(phenyl)benzidine

C44H32N2 (588.2565352)

N,N′-di(1-naphthyl)-N,N′-diphenylbenzidine

C44H32N2 (588.2565352)

C32H44O10 (588.2934324)

ST 27:5;O4;Hex

C33H48O9 (588.3298158)

ST 28:3;O8;S

C28H44O11S (588.2604194)

ST 29:2;O7;S

C29H48O10S (588.2968028)

Bemfivastatin

C34H37FN2O6 (588.2635514)

Bemfivastatin (PPD 10558) is an orally active, HMG-CoA Reductase (HMGCR) inhibitor, also known as Statin. Bemfivastatin enhances the activity of liver extraction. Bemfivastatin exhibits little developmental toxicity effects in pregnant rats and rabbits via daily oral doses during organogenesis period. The no observed adverse effect level (NOAEL) are ≥320?mg/kg/day for rats developmental toxicity, 12.5?mg/kg/day for rabbits maternal toxicity, and 25?mg/kg/day for rabbits developmental toxicity, respectively. Bemfivastatin can be used for research on Statin-related hypercholesterolemic myalgia with inability to tolerate statins[1][2].

4-[(1e,3e,5e,7e,9e,11e,13e,15e,17e)-18-(4-carboxy-2,3-dimethylphenyl)-3,7,12,16-tetramethyloctadeca-1,3,5,7,9,11,13,15,17-nonaen-1-yl]-2,3-dimethylbenzoic acid

C40H44O4 (588.3239424)

(1s,3as,5ar,7r,8s,9ar,9br,10r,11ar)-3a,7,8,10-tetrahydroxy-1-[(2r,4r,5r)-2-[5-(hydroxymethyl)furan-2-yl]-4-methyl-5-(3-methylbutyl)-1,3-dioxolan-4-yl]-9a,11a-dimethyl-1h,2h,3h,5ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-5-one

(1s,3as,5ar,7r,8s,9ar,9br,10r,11ar)-3a,7,8,10-tetrahydroxy-1-[(2r,4r,5r)-2-[5-(hydroxymethyl)furan-2-yl]-4-methyl-5-(3-methylbutyl)-1,3-dioxolan-4-yl]-9a,11a-dimethyl-1h,2h,3h,5ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-5-one

C33H48O9 (588.3298158)

(1r,2s,3s,5s,8r,9s,10r,11s,13r,16s)-11,16-bis(acetyloxy)-5,8,9-trihydroxy-3-(2-hydroxypropan-2-yl)-6,10-dimethyl-14-oxatetracyclo[8.6.0.0³,⁷.0¹³,¹⁶]hexadec-6-en-2-yl benzoate

C31H40O11 (588.257049)

methyl 2-[(1s,3r,4s,5s,7s,8s,9r,12s,13s,16s)-4,16-bis(acetyloxy)-13-(furan-3-yl)-5-hydroxy-6,6,8,12-tetramethyl-17-methylidene-15-oxo-2,14-dioxatetracyclo[7.7.1.0¹,¹².0³,⁸]heptadecan-7-yl]acetate

methyl 2-[(1s,3r,4s,5s,7s,8s,9r,12s,13s,16s)-4,16-bis(acetyloxy)-13-(furan-3-yl)-5-hydroxy-6,6,8,12-tetramethyl-17-methylidene-15-oxo-2,14-dioxatetracyclo[7.7.1.0¹,¹².0³,⁸]heptadecan-7-yl]acetate

C31H40O11 (588.257049)

(1s,2r,4s,5r,9r,10r,13r,14s,15s,17s)-9-(furan-3-yl)-1-hydroxy-15-[(1r)-1-hydroxy-2-methoxy-2-oxoethyl]-10,14,16,16-tetramethyl-7,18-dioxo-3,8-dioxapentacyclo[12.3.1.0²,⁴.0⁴,¹³.0⁵,¹⁰]octadecan-17-yl 2-methylpropanoate

(1s,2r,4s,5r,9r,10r,13r,14s,15s,17s)-9-(furan-3-yl)-1-hydroxy-15-[(1r)-1-hydroxy-2-methoxy-2-oxoethyl]-10,14,16,16-tetramethyl-7,18-dioxo-3,8-dioxapentacyclo[12.3.1.0²,⁴.0⁴,¹³.0⁵,¹⁰]octadecan-17-yl 2-methylpropanoate

C31H40O11 (588.257049)

(1r,2s,3r,10s,19r,22s,23s,24r,26r,29r)-10-acetyl-1,22-dihydroxy-2,22-dimethyl-5,16-dioxo-4,11,17,25-tetraoxahexacyclo[21.3.1.1³,²⁶.1¹⁰,¹⁴.0²,¹⁹.0¹⁹,²⁴]nonacosa-6,14-dien-29-yl acetate

(1r,2s,3r,10s,19r,22s,23s,24r,26r,29r)-10-acetyl-1,22-dihydroxy-2,22-dimethyl-5,16-dioxo-4,11,17,25-tetraoxahexacyclo[21.3.1.1³,²⁶.1¹⁰,¹⁴.0²,¹⁹.0¹⁹,²⁴]nonacosa-6,14-dien-29-yl acetate

(1s,3r,5s,6s,7s,9r,10r,13r,14r,16s,18r,20r,22s,24s,26s)-7,13,26-trihydroxy-1-methoxy-5,9,24-trimethyl-10-(6-oxopyran-3-yl)-2,15,21,23-tetraoxaheptacyclo[20.3.1.0³,²⁰.0⁵,¹⁸.0⁶,¹⁴.0⁹,¹³.0¹⁴,¹⁶]hexacosan-8-one

C31H40O11 (588.257049)

methyl 2-[4,5-bis(acetyloxy)-12-(furan-3-yl)-6,6,8,11,16-pentamethyl-14,17-dioxo-2,13-dioxatetracyclo[7.6.2.0¹,¹¹.0³,⁸]heptadecan-7-yl]acetate

C31H40O11 (588.257049)

1-[2-(furan-3-yl)-2-hydroxyethyl]-2,5-dihydroxy-5-(methoxycarbonyl)-1,4a-dimethyl-4-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-hexahydronaphthalene-2-carboxylic acid

C27H40O14 (588.241794)